Israel - English - Ministry of Health

amgen europe b.v. - darbepoetin alfa - solution for injection - darbepoetin alfa 300 mcg / 0.6 ml - darbepoetin alfa - aranesp ® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (crf) in adults and paediatric patients ≥ 1 year of age.aranesp ® is indicated for the treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.

Israel - English - Ministry of Health

amgen europe b.v. - darbepoetin alfa - solution for injection - darbepoetin alfa 500 mcg/ml - darbepoetin alfa - aranesp ® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (crf) in adults and paediatric patients ≥ 1 year of age.aranesp ® is indicated for the treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.

European Union - English - EMA (European Medicines Agency)

roche registration gmbh - epoetin beta - kidney failure, chronic; anemia; cancer; blood transfusion, autologous - antianemic preparations - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients;treatment of symptomatic anaemia in adult patients with non-myeloid malignancies receiving chemotherapy;increasing the yield of autologous blood from patients in a pre-donation programme. its use in this indication must be balanced against the reported increased risk of thromboembolic events. treatment should only be given to patients with moderate anaemia (hb 10 - 13 g/dl [6.21 - 8.07 mmol/l], no iron deficiency) if blood conserving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males).

New Zealand - English - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - epoetin alfa 33.6 µg/ml (human recombinant erythropoietin (r-huepo cho));  ; epoetin alfa 33.6 µg/ml (human recombinant erythropoietin (r-huepo cho)); epoetin alfa 33.6 µg/ml - solution for injection - 4000 iu/ml - active: epoetin alfa 33.6 µg/ml (human recombinant erythropoietin (r-huepo cho))   excipient: albumin dibasic sodium phosphate dihydrate monobasic sodium phosphate dihydrate polysorbate 80 sodium chloride water for injection active: epoetin alfa 33.6 µg/ml (human recombinant erythropoietin (r-huepo cho)) excipient: albumin dibasic sodium phosphate dihydrate glycine metacresol monobasic sodium phosphate dihydrate water for injection active: epoetin alfa 33.6 µg/ml excipient: albumin dibasic sodium phosphate dihydrate monobasic sodium phosphate dihydrate sodium chloride water

New Zealand - English - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - epoetin alfa 84 µg/ml (human recombinant erythropoietin (r-huepo cho));  ; epoetin alfa 84 µg/ml; epoetin alfa 84 µg/ml - solution for injection - 10000 iu/ml - active: epoetin alfa 84 µg/ml (human recombinant erythropoietin (r-huepo cho))   excipient: albumin dibasic sodium phosphate dihydrate glycine metacresol monobasic sodium phosphate dihydrate polysorbate 80 water for injection active: epoetin alfa 84 µg/ml excipient: albumin dibasic sodium phosphate dihydrate monobasic sodium phosphate dihydrate sodium chloride water for injection active: epoetin alfa 84 µg/ml excipient: albumin monobasic sodium phosphate dihydrate sodium chloride water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - epoetin alfa 168 µg/ml (human recombinant erythropoietin (r-huepo cho));   - solution for injection - 20000 iu/ml - active: epoetin alfa 168 µg/ml (human recombinant erythropoietin (r-huepo cho))   excipient: albumin dibasic sodium phosphate dihydrate glycine metacresol monobasic sodium phosphate dihydrate polysorbate 80 water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - epoetin alfa 16.8 µg/ml (human recombinant erythropoietin (r-huepo cho));  ; epoetin alfa 16.8 µg/ml - solution for injection - 2000 iu/ml - active: epoetin alfa 16.8 µg/ml (human recombinant erythropoietin (r-huepo cho))   excipient: albumin dibasic sodium phosphate dihydrate monobasic sodium phosphate dihydrate polysorbate 80 sodium chloride water for injection active: epoetin alfa 16.8 µg/ml excipient: albumin dibasic sodium phosphate dihydrate monobasic sodium phosphate dihydrate sodium chloride water for injection

Kenya - English - Pharmacy and Poisons Board

crown healthcare crownplex mombasa road, opp jkia flyover, nairobi - erythropoietin - solution for injection - 2000iu/ml - erythropoietin

Kenya - English - Pharmacy and Poisons Board

questa care inc c/o surgilinks ltd nairobi - erythropoietin concentrated solution - solution for injection in pre-filled syringe - 4000iu/ml - erythropoietin

Kenya - English - Pharmacy and Poisons Board

erythropoietin - solution for injection - 30000iu/3.0 ml - erythropoietin